Commercial bovine proteoglycan Is highly arthritogenic and can be used as an alternative antigen source for PGIA Model

Ishikawa, L. L. W., Colavite, P. M., Camargo da Rosa, L. , Balbino, B., França, T. G. D., Zorzella-Pezavento, S. F. G., Chiuso-Minicucci, F. and Sartori, A. (2014) Commercial bovine proteoglycan Is highly arthritogenic and can be used as an alternative antigen source for PGIA Model. BioMed Research International, 2014, 148594. (doi: 10.1155/2014/148594) (PMID:24971313) (PMCID:PMC4058295)

[img] Text
277213.pdf - Published Version
Available under License Creative Commons Attribution.

2MB

Abstract

Rheumatoid arthritis (RA) is the most common systemic autoimmune disease. It affects mainly the joints, causing synovitis, cartilage destruction, and bone erosion. Many experimental models are used to study the mechanisms involved in immunopathogenesis and new therapies for this disease. Proteoglycan-induced arthritis (PGIA) is a widely used model based on the cross-reactivity of injected foreign (usually human) PG and mice self-PG. Considering the complexity of the extraction and purification of human PG, in this study we evaluated the arthritogenicity of bovine PG that is commercially available. Bovine PG was highly arthritogenic, triggering 100% incidence of arthritis in female BALB/c retired breeder mice. Animals immunized with bovine PG presented clinical symptoms and histopathological features similar to human RA and other experimental models. Moreover, bovine PG immunization determined higher levels of proinflammatory and anti-inflammatory cytokines in arthritic mice compared to healthy ones. As expected, only the arthritic group produced IgG1 and IgG2a antibodies against PG. Thus, commercial bovine PG can be used as an alternative antigenic source to PGIA for the study of many RA aspects, including the immunopathogenesis of the disease and also the development of new therapies.

Item Type:Articles
Additional Information:The authors are grateful to Brazilian financial support: Grant number 2011/17325-4, Sao Paulo State Foundation (FAPESP).
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Camargo da Rosa, Dr Larissa
Authors: Ishikawa, L. L. W., Colavite, P. M., Camargo da Rosa, L., Balbino, B., França, T. G. D., Zorzella-Pezavento, S. F. G., Chiuso-Minicucci, F., and Sartori, A.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
Journal Name:BioMed Research International
Publisher:Hindawi
ISSN:2314-6133
ISSN (Online):2314-6141
Copyright Holders:Copyright © 2014 Larissa Lumi Watanabe Ishikawa et al.
First Published:First published in BioMed Research International 2014:148594
Publisher Policy:Reproduced under a Creative Commons licence

University Staff: Request a correction | Enlighten Editors: Update this record